Skip to main content
  • 1258 Accesses

Abstract

Topical medications, such as ointments, creams, and lotions, are frequently used for dermatological treatments. In clinical situations, improper use of topical medications might often be observed. First of all, changes to topical generic medication from an innovator might induce a change in release of the main compound and thus clinical efficacy. Next, there are some precautions during the preparation of an admixture of a topical medication. For example, no differences in the vasoconstriction response were observed with small degrees (16 times) of dilution in a steroid ointment. Another important consideration is the combination effect of a change to a generic medication from an innovator with preparation of the admixture. From a pharmacist’s perspective, three precautions that should be considered when applying topical medications are considered here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Suzuki T, Uchino T, Miyazaki Y, Kagawa Y (2012) Release profiles of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments prepared by different mixing methods. Chem Pharm Bull 60(2):260–266

    Article  CAS  PubMed  Google Scholar 

  2. Tsai JC (2002) Content and transdermal delivery of clobetasol 17-propionate from commercial creams and ointments. J Food Drug Anal 10(1):7–12

    CAS  Google Scholar 

  3. Tsai JC, Cheng CL, Tsai YF, Sheu HM, Chou CH (2004) Evaluation of in vivo bioequivalence methodology for topical clobetasol 17-propionate based on pharmacodynamic modeling using Chinese skin. J Pharm Sci 93(1):207–217

    Article  CAS  PubMed  Google Scholar 

  4. Ohtani M, Yokoyama M, Kotaki H, Kariya S, Iga T (1993) Change in physical stability of the bases after mixing of commercially available ointments and/or creams. Jpn J Hosp Pharm 19(6):493–502

    Article  CAS  Google Scholar 

  5. Ohishi T, Shinagawa R, Harada Y, Nagatani K, Nasu K (1991) Admixture of ointments. J Jpn Soc Hosp Pharm 27:39–47

    Google Scholar 

  6. Ohishi T, Shinagawa R, Harada Y, Takebayashi K, Nasu K (1992) Admixture of ointments. J Jpn Soc Hosp Pharm 28:93–100

    Google Scholar 

  7. Suzuki T, Uchino T, Miyazaki Y, Kagawa Y (2014) The effect of storage time on the release profile of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments. Pharmazie 69(2):104–108

    CAS  PubMed  Google Scholar 

  8. Ohtani M, Nakai T, Ohsawa K, Kim S, Matsumoto M, Etoh T, Kariya S, Kanou S, Uchino K (2002) Effect of admixture of betamethasone butyrate propionate ointment on preservative efficacy. Yakugaku Zasshi 122(12):1153–1158

    Article  CAS  PubMed  Google Scholar 

  9. Kawashima M (1993) Vasoconstriction activity test. Japan-Germany medical reports. 38:13–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomonobu Uchino .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Uchino, T. (2017). Comments from a Pharmacist. In: Sugibayashi, K. (eds) Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56526-0_39

Download citation

Publish with us

Policies and ethics